A Study of TNM001 in Chinese Healthy Preterm and Term Infants

Summary

The purpose of this clinical trial is to evaluate the safety, tolerability and pharmacokinetics (PK) profile of TNM001 injection in healthy preterm and term infants. The main questions it aims to answer are: * the safety and tolerability of TNM001 injection * the pharmacokinetic (PK) profile of TNM001

Timeline

Start

2022-10-25

Primary completion

2023-06-30

Completion

2023-06-30

Drugs

Indications